Table 2. High grade prostate cancer (Gleason score 8 and above) biomarker gene list and differential expression ratio in Cohort II verification sample set (80 disease and 102 controls).
Gene Name# | Description | Sequence Accession ID | Expression Fold Change† | Expression P Value‡ | Expression AUC* |
CRTAM | cytotoxic and regulatory T cell molecule | NM_019604 | 1.58 | 3.46E-05 | 0.67 |
CXCR3 | chemokine (C-X-C motif) receptor 3 | NM_001504 | 1.59 | 3.38E-05 | 0.66 |
FCRL3 | Fc receptor-like 3 | NM_052939 | 1.61 | 2.85E-06 | 0.69 |
KIAA1143 | KIAA1143 | NM_020696 | 1.44 | 1.82E-07 | 0.73 |
KLF12 | Kruppel-like factor 12 | NM_007249; NM_016285 | 1.66 | 8.16E-07 | 0.71 |
TMEM204 | transmembrane protein 204 | NM_024600 | 1.52 | 8.40E-05 | 0.67 |
SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | NM_022136 | – | – | – |
# The 7 biomarkers were picked up from the 10 that were verified in Cohort II samples, using gene-ratio algorithm, based on the best AUC of combined gene-pair.
Determined by qRT-PCR analysis using SAMSN1 as a partner gene, gene ratio was calculated using delta delta Ct calculation.
Calculated by Mann-Whitney test.
area under receiver-operating-characteristic curve.